A comprehensive portfolio of medical technology services spanning development, research, consultation, and device distribution.
Eight specialized service areas designed to support every stage of medical technology development and deployment.
We provide end-to-end healthcare technology services, including the design, development, and deployment of healthcare information systems, clinical management platforms, digital health applications, and medical software solutions. Our team works closely with hospitals, clinics, and healthcare enterprises to deliver tailored technology that streamlines operations and improves patient care.
Our experienced consultants offer strategic advisory services to healthcare institutions, research organizations, and enterprises navigating the complexities of medical technology. We provide guidance on digital transformation roadmaps, regulatory compliance, technology selection and vendor evaluation, and operational efficiency improvement in healthcare settings.
HLZHMED facilitates comprehensive technology exchange and transfer programs, helping organizations acquire, license, and implement proven medical technologies. We manage the full process — from identifying suitable technologies and negotiating licensing terms, to knowledge transfer programs that ensure successful technology adoption within your organization.
We actively promote emerging medical technologies to healthcare providers, research institutions, and industry partners. Our promotion services include market education, demonstration programs, clinical validation support, and liaison services between technology developers and end-users in the Chinese healthcare market.
Our research team conducts systematic experimental studies that advance biomedical knowledge and clinical practice. We support investigator-initiated studies, collaborative clinical research programs, and experimental development projects that bridge the gap between laboratory discovery and clinical application in alignment with Chinese regulatory frameworks.
HLZHMED is at the forefront of human stem cell technology, developing applications for regenerative medicine, disease modeling, and therapeutic innovation. We work with research institutions and clinical centers to develop and apply stem cell-based solutions that address unmet medical needs, guided by China's evolving regulatory standards for advanced cell therapies.
Our precision medicine team develops technologies for human gene-based diagnosis and therapeutic intervention. This includes the development of genetic testing platforms, CRISPR-based tools, gene expression analysis systems, and therapeutic gene delivery solutions — all developed under rigorous scientific and ethical standards to support China's precision medicine initiatives.
HLZHMED is an authorized distributor of Class I and Class II medical devices in China. Our device portfolio covers a range of diagnostic, monitoring, and therapeutic equipment sourced from reputable domestic and international manufacturers. We provide product selection guidance, regulatory documentation support, and after-sales service to ensure our clients receive devices that meet clinical needs and regulatory requirements.